KEY Share Price

Open 3.11 Change Price %
High 3.21 1 Day 0.05 1.58
Low 3.10 1 Week 0.04 1.26
Close 3.21 1 Month 0.21 7.00
Volume 2437 1 Year 1.11 52.86
52 Week High 3.93
52 Week Low 1.97
KEY Important Levels
Resistance 2 3.31
Resistance 1 3.27
Pivot 3.17
Support 1 3.15
Support 2 3.11
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
BRS 12.00 0.00%
BRS 12.00 0.00%
More..
EPA France Top Gainers Stocks
MLGEO 0.06 20.00%
APAM 33.78 15.72%
APAM 33.78 15.72%
MLLOI 3.80 15.15%
DEXB 17.47 13.89%
DEXB 17.47 13.89%
ALDIE 1.40 13.82%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
More..
EPA France Top Losers Stocks
MLTMT 0.01 -50.00%
MLPGO 0.11 -21.43%
MLAAE 6.48 -19.00%
MLEVE 0.09 -18.18%
TVRB 33.51 -8.84%
CGD 74.87 -5.23%
CGD 74.87 -5.23%
CGD 74.87 -5.23%
GENX 2.31 -4.94%
CGM 25.80 -4.76%
More..

Keyrus (EPA: KEY)

KEY Technical Analysis 3
As on 23rd Mar 2017 KEY Share Price closed @ 3.21 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.80 & Buy for SHORT-TERM with Stoploss of 3.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
KEY Target for March
1st Target up-side 3.31
2nd Target up-side 3.54
3rd Target up-side 3.76
1st Target down-side 2.67
2nd Target down-side 2.44
3rd Target down-side 2.22
KEY Other Details
Segment EQ
Market Capital 0.00
Sector Technology
Industry Information Technology Services
Offical website http://www.keyrus.com
KEY Address
KEY
155 rue Anatole France
Cedex
Levallois-Perret, 92593
France
Phone: 33 1 41 34 10 00
Fax: 33 1 41 34 10 10
KEY Latest News
BRIEF-Xplus Q4 net profit slightly up at 789144 zlotys   Reuters   - 15th Feb 17
BRIEF-Keyrus Q4 consolidated revenues rise to 62.3 million euros   Reuters   - 14th Feb 17
Helsinn Healthcare SA: Mundipharma and Helsinn Group Expand Exclusive ...   PharmiWeb.com (press release)   - 14th Feb 17
Talend Reports Record Fourth Quarter and Fiscal Year 2016 Financial Results   Business Wire (press release)   - 10th Feb 17
How Healthcare Analytics can Revolutionise the Health Care   RNews   - 16th Jan 17
US FDA Approves Biogen's SPINRAZA™ (nusinersen), The First Treatment for ...   PharmiWeb.com (press release)   - 24th Dec 16
ADMEDUS ANNOUNCES POSITIVE UNBLINDED HSV-2 PHASE II INTERIM DATA   PharmiWeb.com (press release)   - 19th Oct 16
Speaker   ITWeb   - 06th Oct 16
BIPB, an Existing South African Operation of the International Keyrus Group ...   PR Newswire UK (press release)   - 05th Sep 16
Cookies on Pharmiweb.Com   PharmiWeb.com (press release)   - 19th Jul 16
Interactive Technical Analysis Chart Keyrus ( KEY EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Keyrus
KEY Business Profile
Keyrus Société Anonyme provides consulting, solutions integration, and performance management services worldwide. It offers executive services, including management consulting, and Web strategy consulting and digital marketing services. The company also provides performance solutions services comprising business intelligence and performance management; e-business and Web performance; and ERP-BI-CRM integrated management solutions. It serves banking and finance, energy and utilities, public, healthcare, insurance, and pharmaceuticals and life sciences sectors; distribution, retail, and services sectors; and telecommunications/IT/media industries, as well as for the mid market. Keyrus Société Anonyme was founded in 1996 and is headquartered in Levallois-Perret, France.